$XTIA
XTI Aerospace, Inc. Stock $xtia

$xtia Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000162828022006421 Filed on March 16, 2022

Income Statement

Concept	2021 Q4	2021 Q3	2021
Revenue	$5.138M	$4.450M	$16.00M
YoY Change	33.11%	74.24%	72.04%
Cost Of Revenue	$1.408M	$1.186M	$4.374M
YoY Change	22.43%	83.88%	67.39%
Gross Profit	$3.730M	$3.264M	$11.62M
YoY Change	37.64%	70.98%	73.86%
Gross Profit Margin	72.6%	73.35%	72.65%
Selling, General & Admin	$16.92M	$10.98M	$49.61M
YoY Change	166.1%	89.08%	140.93%
% of Gross Profit	453.73%	336.34%	426.93%
Research & Development	$4.936M	$3.254M	$14.10M
YoY Change	125.39%	89.52%	116.92%
% of Gross Profit	132.33%	99.69%	121.33%
Depreciation & Amortization	$1.910M	$1.909M	$6.451M
YoY Change	117.05%	218.17%	90.86%
% of Gross Profit	51.21%	58.49%	55.51%
Operating Expenses	$23.24M	$15.72M	$84.24M
YoY Change	156.78%	92.77%	176.39%
Operating Profit	-$19.51M	-$12.46M	-$72.62M
YoY Change	207.71%	99.42%	205.19%
Interest Expense	-$5.825M	-$22.30M	-$55.91M
YoY Change	921.93%	4029.63%	2017.95%
% of Operating Profit
Other Income/Expense, Net	-$637.0K	-$22.35M	$1.075M
YoY Change	-24.17%	1754.52%	-119.63%
Pretax Income	-$40.91M	-$34.80M	-$71.54M
YoY Change	395.28%	367.09%	144.42%
Income Tax	-$2.762M	-$900.0K	-$1.412M
% Of Pretax Income
Net Earnings	-$37.72M	-$33.64M	-$69.16M
YoY Change	354.97%	350.52%	136.6%
Net Earnings / Revenue	-734.08%	-755.96%	-432.35%
Basic Earnings Per Share		-$0.31	-$0.72
Diluted Earnings Per Share	-$302.3K	-$0.31	-$0.72
COMMON SHARES
Basic Shares Outstanding	152.5M shares	117.8M shares	108.0M shares
Diluted Shares Outstanding		117.8M shares	108.0M shares

Balance Sheet

Concept	2021 Q4	2021 Q3	2021
SHORT-TERM ASSETS
Cash & Short-Term Investments	$95.61M	$110.0M	$95.61M
YoY Change	267.71%	250.34%	267.85%
Cash & Equivalents	$52.48M	$66.80M	$52.48M
Short-Term Investments	$43.13M	$43.22M	$43.13M
Other Short-Term Assets	$4.842M	$1.120M	$4.842M
YoY Change	303.5%	1.82%	303.5%
Inventory	$1.976M	$1.540M	$1.976M
Prepaid Expenses
Receivables	$3.218M	$3.432M	$3.218M
Other Receivables	$321.0K	$888.0K	$321.0K
Total Short-Term Assets	$106.0M	$117.0M	$106.0M
YoY Change	249.42%	231.41%	249.36%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.442M	$1.483M	$3.178M
YoY Change	-0.21%	-32.59%	-9.72%
Goodwill	$7.672M	$24.02M
YoY Change	16.45%
Intangibles	$33.48M	$34.78M
YoY Change	135.71%
Long-Term Investments	$2.500M	$10.16M	$4.338M
YoY Change	0.0%		73.52%
Other Assets	$253.0K	$139.0K	$253.0K
YoY Change	66.45%	39.0%	68.67%
Total Long-Term Assets	$50.71M	$74.05M	$50.71M
YoY Change	76.78%	328.03%	76.82%
TOTAL ASSETS
Total Short-Term Assets	$106.0M	$117.0M	$106.0M
Total Long-Term Assets	$50.71M	$74.05M	$50.71M
Total Assets	$156.7M	$191.0M	$156.7M
YoY Change	165.5%	263.19%	165.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.414M	$1.394M	$2.414M
YoY Change	165.86%	74.25%	165.27%
Accrued Expenses	$10.67M	$6.623M	$11.31M
YoY Change	289.38%	164.92%	233.57%
Deferred Revenue	$4.800M	$4.500M
YoY Change	152.63%
Short-Term Debt	$3.490M	$3.251M	$0.00
YoY Change	-35.38%
Long-Term Debt Due	$3.490M	$3.251M	$3.490M
YoY Change	-35.37%	-47.56%	-35.37%
Total Short-Term Liabilities	$27.13M	$20.17M	$27.13M
YoY Change	123.91%	68.12%	123.85%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$28.00K	$28.00K	$1.356M
YoY Change	300.0%	-97.45%	-38.64%
Total Long-Term Liabilities	$28.00K	$28.00K	$1.356M
YoY Change	300.0%	-97.45%	-38.64%
TOTAL LIABILITIES
Total Short-Term Liabilities	$27.13M	$20.17M	$27.13M
Total Long-Term Liabilities	$28.00K	$28.00K	$1.356M
Total Liabilities	$28.49M	$26.66M	$30.18M
YoY Change	98.78%	101.95%	109.99%
SHAREHOLDERS EQUITY
Retained Earnings	-$250.3M	-$212.6M
YoY Change	38.3%
Common Stock	$124.0K	$125.0K
YoY Change	133.96%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$695.0K	$695.0K
YoY Change	0.0%
Treasury Stock Shares	1.000 shares	1.000 shares
Shareholders Equity	$81.80M	$122.4M	$126.5M
YoY Change
Total Liabilities & Shareholders Equity	$156.7M	$191.0M	$156.7M
YoY Change	165.5%	263.19%	165.5%

Cashflow Statement

Concept	2021 Q4	2021 Q3	2021
OPERATING ACTIVITIES
Net Income	-$37.72M	-$33.64M	-$69.16M
YoY Change	354.97%	350.52%	136.6%
Depreciation, Depletion And Amortization	$1.910M	$1.909M	$6.451M
YoY Change	117.05%	218.17%	90.86%
Cash From Operating Activities	-$13.11M	-$9.855M	-$37.13M
YoY Change	159.66%	90.25%	80.24%
INVESTING ACTIVITIES
Capital Expenditures	-$254.0K	-$593.0K	$346.0K
YoY Change	-57.67%	-21.97%	-64.4%
Acquisitions			-$184.0K
YoY Change
Other Investing Activities	-$546.0K	$1.732M	-$52.14M
YoY Change	-96.96%	-146.81%	140.6%
Cash From Investing Activities	-$800.0K	$1.139M	-$53.51M
YoY Change	-95.69%	-125.54%	127.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-388.0K	50.48M	$125.0M
YoY Change	-103.8%	3243.05%	118.37%
NET CHANGE
Cash From Operating Activities	-13.11M	-9.855M	-$37.13M
Cash From Investing Activities	-800.0K	1.139M	-$53.51M
Cash From Financing Activities	-388.0K	50.48M	$125.0M
Net Change In Cash	-14.30M	41.76M	$34.48M
YoY Change	6.56%	-613.7%	162.3%
FREE CASH FLOW
Cash From Operating Activities	-$13.11M	-$9.855M	-$37.13M
Capital Expenditures	-$254.0K	-$593.0K	$346.0K
Free Cash Flow	-$12.86M	-$9.262M	-$37.48M
YoY Change	188.97%	109.55%	73.72%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001529113
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2020Q1	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.02222
CY2020Q1	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.0222
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	001-36404
CY2021	dei	Entity Registrant Name EntityRegistrantName	INPIXON
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	88-0434915
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	2479 E. Bayshore Road
CY2021	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 195
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Palo Alto
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94303
CY2021	dei	City Area Code CityAreaCode	408
CY2021	dei	Local Phone Number LocalPhoneNumber	702-2167
CY2021	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001
CY2021	dei	Trading Symbol TradingSymbol	INPX
CY2021	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	true
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	132741195	USD
CY2021Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	152476355	shares
CY2021	dei	Auditor Firm AuditorFirmId	688
CY2021	dei	Auditor Name AuditorName	Marcum llp
CY2021	dei	Auditor Location AuditorLocation	New York NY
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	52480000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17996000	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	272000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	235000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3218000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1739000	USD
CY2021Q4	inpx	Notes And Other Receivables Net NotesAndOtherReceivablesNet	321000	USD
CY2020Q4	inpx	Notes And Other Receivables Net NotesAndOtherReceivablesNet	152000	USD
CY2021Q4	us-gaap	Fifo Inventory Amount FIFOInventoryAmount	1976000	USD
CY2020Q4	us-gaap	Fifo Inventory Amount FIFOInventoryAmount	1243000	USD
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	43125000	USD
CY2020Q4	us-gaap	Short Term Investments ShortTermInvestments	7998000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4842000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1197000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	105962000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	30325000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1442000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1445000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1736000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2077000	USD
CY2021Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	1792000	USD
CY2020Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	1721000	USD
CY2021Q4	us-gaap	Equity Securities Fvni Noncurrent EquitySecuritiesFVNINoncurrent	1838000	USD
CY2020Q4	us-gaap	Equity Securities Fvni Noncurrent EquitySecuritiesFVNINoncurrent	0	USD
CY2021Q4	us-gaap	Other Long Term Investments OtherLongTermInvestments	2500000	USD
CY2020Q4	us-gaap	Other Long Term Investments OtherLongTermInvestments	2500000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	33478000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	14203000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	7672000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	6588000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	253000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	152000	USD
CY2021Q4	us-gaap	Assets Assets	156673000	USD
CY2020Q4	us-gaap	Assets Assets	59011000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2414000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	908000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10665000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2739000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	643000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	647000	USD
CY2021Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4805000	USD
CY2020Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1922000	USD
CY2021Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	3490000	USD
CY2020Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	5401000	USD
CY2021Q4	inpx	Acquisition Liability Current AcquisitionLiabilityCurrent	5114000	USD
CY2020Q4	inpx	Acquisition Liability Current AcquisitionLiabilityCurrent	500000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	27131000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	12117000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1108000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1457000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	28000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	7000	USD
CY2021Q4	inpx	Acquisition Liability Noncurrent AcquisitionLiabilityNoncurrent	220000	USD
CY2020Q4	inpx	Acquisition Liability Noncurrent AcquisitionLiabilityNoncurrent	750000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	28487000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	14331000	USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	124440924	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	53178462	shares
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	695000	USD
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	124440923	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	53178462	shares
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	124000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	53000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	332639000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	225613000	USD
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	1	shares
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	695000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	44000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	660000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-250309000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-180992000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	81803000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	44639000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15995000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9297000	USD
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	41352000	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	15261000	USD
CY2021Q4	us-gaap	Minority Interest MinorityInterest	1688000	USD
CY2020Q4	us-gaap	Minority Interest MinorityInterest	41000	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	83491000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	44680000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	156673000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	59011000	USD
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	4374000	USD
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	2613000	USD
CY2021	us-gaap	Gross Profit GrossProfit	11621000	USD
CY2020	us-gaap	Gross Profit GrossProfit	6684000	USD
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14121000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6523000	USD
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	8261000	USD
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5331000	USD
CY2021	inpx	Acquisition Cost Of Business AcquisitionCostOfBusiness	1248000	USD
CY2020	inpx	Acquisition Cost Of Business AcquisitionCostOfBusiness	1057000	USD
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	14789000	USD
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4467000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2306000	USD
CY2021	us-gaap	Operating Expenses OperatingExpenses	84238000	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	30478000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-72617000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-23794000	USD
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1183000	USD
CY2020	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2426000	USD
CY2021	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	-30000	USD
CY2020	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	-210000	USD
CY2021	inpx	Financing Receivable Credit Loss Expense Reversal Loans Held For Sale FinancingReceivableCreditLossExpenseReversalLoansHeldForSale	-7345000	USD
CY2020	inpx	Financing Receivable Credit Loss Expense Reversal Loans Held For Sale FinancingReceivableCreditLossExpenseReversalLoansHeldForSale	2370000	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-173000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-470000	USD
CY2021	inpx	Gain Loss On Financing Receivable Settlement GainLossOnFinancingReceivableSettlement	49817000	USD
CY2020	inpx	Gain Loss On Financing Receivable Settlement GainLossOnFinancingReceivableSettlement	0	USD
CY2021	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-57067000	USD
CY2020	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	0	USD
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1075000	USD
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5476000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-71542000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-29270000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1412000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-56000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	-70130000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-29214000	USD
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-975000	USD
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	15000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-77316000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-77316000	USD
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28800493	shares
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-69155000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-29229000	USD
CY2021	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	8161000	USD
CY2020	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	0	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-29229000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-29229000	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.72
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.72
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.01
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.01
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	107981441	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	107981441	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28800493	shares
CY2021	us-gaap	Profit Loss ProfitLoss	-70130000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-29214000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-617000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	566000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-70747000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-28648000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	44680000	USD
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	2500000	USD
CY2021	inpx	Common Shares Issued For Net Proceeds From Warrants Exercised CommonSharesIssuedForNetProceedsFromWarrantsExercised	3779000	USD
CY2021	inpx	Stock Options Granted To Employees And Consultants For Services StockOptionsGrantedToEmployeesAndConsultantsForServices	10879000	USD
CY2021	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
CY2021	us-gaap	Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet	-1855000	USD
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	4551000	USD
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	9500000	USD
CY2021	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	8161000	USD
CY2021	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures	1000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-628000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	-70130000	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	83491000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6050000	USD
CY2020	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	9936000	USD
CY2020	inpx	Stock During Issued Common Shares For Extinguishment Of Debenture Liability StockDuringIssuedCommonSharesForExtinguishmentOfDebentureLiability	200000	USD
CY2020	inpx	Common Shares Issued For Net Proceeds From Warrants Exercised Shares CommonSharesIssuedForNetProceedsFromWarrantsExercisedShares	3000000	shares
CY2020	inpx	Common Shares Issued For Net Proceeds From Warrants Exercised CommonSharesIssuedForNetProceedsFromWarrantsExercised	3000	USD
CY2020	inpx	Common Shares Issued For Net Proceeds From Warrants Exercised CommonSharesIssuedForNetProceedsFromWarrantsExercised	3000	USD
CY2020	inpx	Stock Options Granted To Employees And Consultants For Services StockOptionsGrantedToEmployeesAndConsultantsForServices	1193000	USD
CY2020	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	600000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	564000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-29214000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	44680000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	-70130000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-29214000	USD
CY2021	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	1344000	USD
CY2020	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	826000	USD
CY2021	inpx	Amortization Of Intangible Assets Including Other Amortization AmortizationOfIntangibleAssetsIncludingOtherAmortization	5107000	USD
CY2020	inpx	Amortization Of Intangible Assets Including Other Amortization AmortizationOfIntangibleAssetsIncludingOtherAmortization	2545000	USD
CY2021	inpx	Amortization Of Right Of Use Asset AmortizationOfRightOfUseAsset	677000	USD
CY2020	inpx	Amortization Of Right Of Use Asset AmortizationOfRightOfUseAsset	490000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	10879000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	1194000	USD
CY2021	inpx	Business Combination Post Combination Expense BusinessCombinationPostCombinationExpense	6524000	USD
CY2020	inpx	Business Combination Post Combination Expense BusinessCombinationPostCombinationExpense	0	USD
CY2021	inpx	Debt And Equity Securities Gain Loss1 DebtAndEquitySecuritiesGainLoss1	-30000	USD
CY2020	inpx	Debt And Equity Securities Gain Loss1 DebtAndEquitySecuritiesGainLoss1	-210000	USD
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	224000	USD
CY2020	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2594000	USD
CY2021	inpx	Accrued Interest Income Related Party Operating Activities AccruedInterestIncomeRelatedPartyOperatingActivities	1627000	USD
CY2020	inpx	Accrued Interest Income Related Party Operating Activities AccruedInterestIncomeRelatedPartyOperatingActivities	32000	USD
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	121000	USD
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	956000	USD
CY2021	inpx	Unrealized Gain Loss On Note Receivable UnrealizedGainLossOnNoteReceivable	92000	USD
CY2020	inpx	Unrealized Gain Loss On Note Receivable UnrealizedGainLossOnNoteReceivable	0	USD
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	300000	USD
CY2020	us-gaap	Inventory Write Down InventoryWriteDown	138000	USD
CY2021	inpx	Financing Receivable Credit Loss Expense Reversal Loans Held For Sale FinancingReceivableCreditLossExpenseReversalLoansHeldForSale	-7345000	USD
CY2020	inpx	Financing Receivable Credit Loss Expense Reversal Loans Held For Sale FinancingReceivableCreditLossExpenseReversalLoansHeldForSale	2370000	USD
CY2021	inpx	Financing Receivable Credit Loss Expense Reversal Related Party Note Receivable FinancingReceivableCreditLossExpenseReversalRelatedPartyNoteReceivable	0	USD
CY2020	inpx	Financing Receivable Credit Loss Expense Reversal Related Party Note Receivable FinancingReceivableCreditLossExpenseReversalRelatedPartyNoteReceivable	648000	USD
CY2021	inpx	Gain Loss On Financing Receivable Settlement GainLossOnFinancingReceivableSettlement	49817000	USD
CY2020	inpx	Gain Loss On Financing Receivable Settlement GainLossOnFinancingReceivableSettlement	0	USD
CY2021	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-2593000	USD
CY2020	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-87000	USD
CY2021	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-57067000	USD
CY2020	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	0	USD
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	14789000	USD
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-24000	USD
CY2020	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2021	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	235000	USD
CY2020	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-6000	USD
CY2021	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	313000	USD
CY2020	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	964000	USD
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	112000	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	117000	USD
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4006000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	563000	USD
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-199000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	248000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	391000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1815000	USD
CY2021	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	490000	USD
CY2020	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	453000	USD
CY2020	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	269000	USD
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	16000	USD
CY2020	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	0	USD
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	817000	USD
CY2020	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	242000	USD
CY2021	inpx	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-658000	USD
CY2020	inpx	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-490000	USD
CY2021	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	328000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-37131000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-20601000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	346000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	972000	USD
CY2021	inpx	Investment In Capitalized Software InvestmentInCapitalizedSoftware	1019000	USD
CY2020	inpx	Investment In Capitalized Software InvestmentInCapitalizedSoftware	862000	USD
CY2021	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	2000000	USD
CY2020	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	7998000	USD
CY2021	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	2000000	USD
CY2020	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	0	USD
CY2021	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	63362000	USD
CY2020	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	0	USD
CY2021	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	28000000	USD
CY2020	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	USD
CY2021	inpx	Payments For Investment In Intangible Assets PaymentsForInvestmentInIntangibleAssets	900000	USD
CY2020	inpx	Payments For Investment In Intangible Assets PaymentsForInvestmentInIntangibleAssets	2200000	USD
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	4000	USD
CY2020	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
CY2021	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	0	USD
CY2020	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	1500000	USD
CY2021	inpx	Payments To Acquire Business Two Gross PaymentsToAcquireBusinessTwoGross	0	USD
CY2020	inpx	Payments To Acquire Business Two Gross PaymentsToAcquireBusinessTwoGross	7786000	USD
CY2021	inpx	Payments To Acquire Business Three Gross PaymentsToAcquireBusinessThreeGross	1023000	USD
CY2021Q4	inpx	Working Capital Deficiency WorkingCapitalDeficiency	78800000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	52500000	USD
CY2020	inpx	Payments To Acquire Business Three Gross PaymentsToAcquireBusinessThreeGross	0	USD
CY2021	inpx	Proceeds To Acquire Businesses Four Gross ProceedsToAcquireBusinessesFourGross	184000	USD
CY2020	inpx	Proceeds To Acquire Businesses Four Gross ProceedsToAcquireBusinessesFourGross	0	USD
CY2021	inpx	Payments To Acquire Business Five Gross PaymentsToAcquireBusinessFiveGross	14977000	USD
CY2020	inpx	Payments To Acquire Business Five Gross PaymentsToAcquireBusinessFiveGross	0	USD
CY2021	inpx	Payments To Acquire Business Six Gross PaymentsToAcquireBusinessSixGross	61000	USD
CY2020	inpx	Payments To Acquire Business Six Gross PaymentsToAcquireBusinessSixGross	0	USD
CY2021	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	0	USD
CY2020	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	2500000	USD
CY2021	inpx	Cash Acquired From Acquisition Gross CashAcquiredFromAcquisitionGross	0	USD
CY2020	inpx	Cash Acquired From Acquisition Gross CashAcquiredFromAcquisitionGross	311000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-53508000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-23507000	USD
CY2021	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	0	USD
CY2020	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-150000	USD
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	43100000	USD
CY2021	us-gaap	Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants	50585000	USD
CY2020	us-gaap	Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants	0	USD
CY2021	inpx	Proceeds From Issuance Of Common Stock And Warrants ProceedsFromIssuanceOfCommonStockAndWarrants	77852000	USD
CY2020	inpx	Proceeds From Issuance Of Common Stock And Warrants ProceedsFromIssuanceOfCommonStockAndWarrants	55352000	USD
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1855000	USD
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	USD
CY2020	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	74000	USD
CY2021	inpx	Loans To Related Party LoansToRelatedParty	117000	USD
CY2020	inpx	Loans To Related Party LoansToRelatedParty	2569000	USD
CY2021	inpx	Proceeds From Related Parties Debt ProceedsFromRelatedPartiesDebt	0	USD
CY2020	inpx	Proceeds From Related Parties Debt ProceedsFromRelatedPartiesDebt	200000	USD
CY2021	us-gaap	Proceeds From Unsecured Notes Payable ProceedsFromUnsecuredNotesPayable	0	USD
CY2020	us-gaap	Proceeds From Unsecured Notes Payable ProceedsFromUnsecuredNotesPayable	5000000	USD
CY2021	inpx	Repayment Of Acquisition One Liability To Shareholders RepaymentOfAcquisitionOneLiabilityToShareholders	461000	USD
CY2020	inpx	Repayment Of Acquisition One Liability To Shareholders RepaymentOfAcquisitionOneLiabilityToShareholders	0	USD
CY2021	inpx	Repayment Of Acquisition Two Liability To Shareholders RepaymentOfAcquisitionTwoLiabilityToShareholders	467000	USD
CY2020	inpx	Repayment Of Acquisition Two Liability To Shareholders RepaymentOfAcquisitionTwoLiabilityToShareholders	0	USD
CY2021	inpx	Repayment Of Acquisition Three Liability To Shareholders RepaymentOfAcquisitionThreeLiabilityToShareholders	500000	USD
CY2020	inpx	Repayment Of Acquisition Three Liability To Shareholders RepaymentOfAcquisitionThreeLiabilityToShareholders	500000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	125037000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	57259000	USD
CY2021	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	86000	USD
CY2020	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-4000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	34484000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	13147000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17996000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4849000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	52480000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17996000	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	3000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	4000	USD
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2389000	USD
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	USD
CY2021	inpx	Stock During Issued Common Shares For Extinguishment Of Liability StockDuringIssuedCommonSharesForExtinguishmentOfLiability	0	USD
CY2020	inpx	Stock During Issued Common Shares For Extinguishment Of Liability StockDuringIssuedCommonSharesForExtinguishmentOfLiability	200000	USD
CY2021	inpx	Common Shares Issued For Extinguishment Of Debt CommonSharesIssuedForExtinguishmentOfDebt	2500000	USD
CY2020	inpx	Common Shares Issued For Extinguishment Of Debt CommonSharesIssuedForExtinguishmentOfDebt	9936000	USD
CY2021	inpx	Right Of Use Asset Obtained In Exchange For Lease Liability RightOfUseAssetObtainedInExchangeForLeaseLiability	401000	USD
CY2020	inpx	Right Of Use Asset Obtained In Exchange For Lease Liability RightOfUseAssetObtainedInExchangeForLeaseLiability	557000	USD
CY2021	inpx	Settlement Of Related Party Note Though Non Cash Payments Amount SettlementOfRelatedPartyNoteThoughNonCashPaymentsAmount	7462000	USD
CY2020	inpx	Settlement Of Related Party Note Though Non Cash Payments Amount SettlementOfRelatedPartyNoteThoughNonCashPaymentsAmount	0	USD
CY2021	us-gaap	Increase Decrease In Equity Securities Fv Ni IncreaseDecreaseInEquitySecuritiesFvNi	58905000	USD
CY2020	us-gaap	Increase Decrease In Equity Securities Fv Ni IncreaseDecreaseInEquitySecuritiesFvNi	0	USD
CY2021	inpx	Noncash Or Part Noncash Acquisition One Noncash Financial Or Equity Instrument Consideration Shares Issued Amount NoncashOrPartNoncashAcquisitionOneNoncashFinancialOrEquityInstrumentConsiderationSharesIssuedAmount	0	USD
CY2020	inpx	Noncash Or Part Noncash Acquisition One Noncash Financial Or Equity Instrument Consideration Shares Issued Amount NoncashOrPartNoncashAcquisitionOneNoncashFinancialOrEquityInstrumentConsiderationSharesIssuedAmount	600000	USD
CY2021	inpx	Noncash Or Part Noncash Acquisition Two Noncash Financial Or Equity Instrument Consideration Shares Issued Amount NoncashOrPartNoncashAcquisitionTwoNoncashFinancialOrEquityInstrumentConsiderationSharesIssuedAmount	10000000	USD
CY2020	inpx	Noncash Or Part Noncash Acquisition Two Noncash Financial Or Equity Instrument Consideration Shares Issued Amount NoncashOrPartNoncashAcquisitionTwoNoncashFinancialOrEquityInstrumentConsiderationSharesIssuedAmount	0	USD
CY2021	inpx	Noncash Or Part Noncash Acquisition Three Noncash Financial Or Equity Instrument Consideration Shares Issued Amount NoncashOrPartNoncashAcquisitionThreeNoncashFinancialOrEquityInstrumentConsiderationSharesIssuedAmount	1403000	USD
CY2020	inpx	Noncash Or Part Noncash Acquisition Three Noncash Financial Or Equity Instrument Consideration Shares Issued Amount NoncashOrPartNoncashAcquisitionThreeNoncashFinancialOrEquityInstrumentConsiderationSharesIssuedAmount	0	USD
CY2021	inpx	Noncash Or Part Noncash Acquisition Four Noncash Financial Or Equity Instrument Consideration Shares Issued Amount NoncashOrPartNoncashAcquisitionFourNoncashFinancialOrEquityInstrumentConsiderationSharesIssuedAmount	429000	USD
CY2020	inpx	Noncash Or Part Noncash Acquisition Four Noncash Financial Or Equity Instrument Consideration Shares Issued Amount NoncashOrPartNoncashAcquisitionFourNoncashFinancialOrEquityInstrumentConsiderationSharesIssuedAmount	0	USD
CY2021	inpx	Preferred Shares Converted Into Common Stock PreferredSharesConvertedIntoCommonStock	9500000	USD
CY2020	inpx	Preferred Shares Converted Into Common Stock PreferredSharesConvertedIntoCommonStock	0	USD
CY2021Q4	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-77300000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-77300000	USD
CY2021Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	15800000	shares
CY2021Q1	inpx	Warrants Issued To Purchase Common Stock WarrantsIssuedToPurchaseCommonStock	44305088	shares
CY2021Q1	inpx	Proceeds From Issuance Of Common Stock And Warrants ProceedsFromIssuanceOfCommonStockAndWarrants	77900000	USD
CY2021Q3	us-gaap	Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants	50600000	USD
CY2020Q2	inpx	Aggregate Offering Amount AggregateOfferingAmount	150000000	USD
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during each of the reporting periods. Actual results could differ from those estimates. The Company’s significant estimates consist of:</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the valuation of stock-based compensation;</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the valuation of the assets and liabilities acquired of Sysat, Ten Degrees, Nanotron, Game your Game, Visualix, CXApp, and Intranav as described in Note 4 , Note 5, Note 6, Note 7 , Note 8, Note 9 and Note 10 respectively, as well as the valuation of the Company’s common shares issued in the transaction;</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the allowance for credit losses;</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the valuation of loans receivable;</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the valuation of equity securities;</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the valuation allowance for deferred tax assets; and</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">impairment of long-lived assets and goodwill.</span></div>
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	300000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	200000	USD
CY2021Q4	us-gaap	Inventory Adjustments InventoryAdjustments	400000	USD
CY2020Q4	us-gaap	Inventory Adjustments InventoryAdjustments	100000	USD
CY2021	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	200000	USD
CY2020	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	0	USD
CY2021	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-57100000	USD
CY2020	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	0	USD
CY2020	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	USD
CY2021	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	USD
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	14800000	USD
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14100000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6500000	USD
CY2021Q4	us-gaap	Minority Interest MinorityInterest	1700000	USD
CY2020Q4	us-gaap	Minority Interest MinorityInterest	41000	USD
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-600000	USD
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	600000	USD
CY2021	inpx	Revenue From Contract With Customer Stated Term RevenueFromContractWithCustomerStatedTerm	P1Y
CY2021	inpx	Revenue From Contract With Customer Renewal Option RevenueFromContractWithCustomerRenewalOption	P1Y
CY2021	inpx	Revenue From Contract With Customer Term For Students RevenueFromContractWithCustomerTermForStudents	P2Y
CY2021Q4	inpx	Deferred Revenue Associated With Software License Agreements DeferredRevenueAssociatedWithSoftwareLicenseAgreements	4800000	USD
CY2020Q4	inpx	Deferred Revenue Associated With Software License Agreements DeferredRevenueAssociatedWithSoftwareLicenseAgreements	1900000	USD
CY2021	us-gaap	Advertising Expense AdvertisingExpense	400000	USD
CY2020	us-gaap	Advertising Expense AdvertisingExpense	1300000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	10900000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	1200000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-29229000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-69155000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-29229000	USD
CY2021	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	8161000	USD
CY2020	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	0	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-77316000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-77316000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-29229000	USD
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	107981441	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	107981441	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28800493	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28800493	shares
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.72
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.72
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.01
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.01
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	165743426	shares
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	13544153	shares
CY2020Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	5000000	shares
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15995000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9297000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15995000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9297000	USD
CY2021	inpx	Term Of License Grant TermOfLicenseGrant	P15Y
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	463000	USD
CY2020Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	211000	USD
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	539000	USD
CY2020Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	137000	USD
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1412000	USD
CY2020Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1033000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1442000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	1976000	USD
CY2021Q4	us-gaap	Inventory Gross InventoryGross	2414000	USD
CY2020Q4	us-gaap	Inventory Gross InventoryGross	1381000	USD
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	438000	USD
CY2020Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	138000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	1243000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3326000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2582000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1884000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1137000	USD
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	100000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1445000	USD
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	400000	USD
CY2021Q4	us-gaap	Equity Securities Fv Ni Cost EquitySecuritiesFvNiCost	58905000	USD
CY2021Q4	us-gaap	Equity Securities Fvni Noncurrent EquitySecuritiesFVNINoncurrent	1838000	USD
CY2021	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-57100000	USD
CY2021	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	0	USD
CY2021Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	4463000	USD
CY2020Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	5275000	USD
CY2021Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	2671000	USD
CY2020Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	3554000	USD
CY2021Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	1792000	USD
CY2020Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	1721000	USD
CY2021	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P3Y
CY2021	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	900000	USD
CY2020	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	700000	USD
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	14800000	USD
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2019Q4	us-gaap	Goodwill Goodwill	2070000	USD
CY2020	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	4292000	USD
CY2020	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	226000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	6588000	USD
CY2021	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	18400000	USD
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	14789000	USD
CY2021	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	-2234000	USD
CY2021	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-293000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	7672000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	40433000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	35589000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	6955000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	21386000	USD
CY2021	us-gaap	Adjustment For Amortization AdjustmentForAmortization	5100000	USD
CY2020	us-gaap	Adjustment For Amortization AdjustmentForAmortization	2500000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	6144000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	5994000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	5038000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	4405000	USD
CY2021Q4	inpx	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	11897000	USD
CY2020Q2	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	200000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	33478000	USD
CY2020Q4	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	1800000	USD
CY2020Q4	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	1800000	USD
CY2020Q4	us-gaap	Equity Method Investments EquityMethodInvestments	2500000	USD
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	2500000	USD
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4805000	USD
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1922000	USD
CY2021Q4	inpx	Accrued Compensation And Employee Benefits Current AccruedCompensationAndEmployeeBenefitsCurrent	8027000	USD
CY2020Q4	inpx	Accrued Compensation And Employee Benefits Current AccruedCompensationAndEmployeeBenefitsCurrent	1266000	USD
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	1012000	USD
CY2020Q4	us-gaap	Interest Payable Current InterestPayableCurrent	536000	USD
CY2021Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	597000	USD
CY2020Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	426000	USD
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	707000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	497000	USD
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	322000	USD
CY2020Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	14000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10665000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2739000	USD
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	0	USD
CY2020Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	254000	USD
CY2021Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	3490000	USD
CY2020Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	5401000	USD
CY2020Q4	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	9200000	USD
CY2021Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	27800000	USD
CY2021Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	3000000	shares
CY2021Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	27800000	USD
CY2021Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	18500000	USD
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q3	us-gaap	Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants	50600000	USD
CY2020Q1	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	1896557	shares
CY2020Q2	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	3889990	shares
CY2020Q4	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	9200000	USD
CY2021Q1	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	893921	shares
CY2021Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	4977	shares
CY2021Q2	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	4672988	shares
CY2021Q2	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	921838	shares
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	414	shares
CY2021Q3	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	877192	shares
CY2021Q3	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited	337500	shares
CY2021Q4	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited	152796	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q3	us-gaap	Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants	50600000	USD
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2021Q4	inpx	Share Based Compensation Options Grant Exercise Price Limit Of Fair Value ShareBasedCompensationOptionsGrantExercisePriceLimitOfFairValue	1
CY2021Q4	inpx	Share Based Compensation Options Grant Exercise Price Limit Of Fair Value10 Percent Owner ShareBasedCompensationOptionsGrantExercisePriceLimitOfFairValue10PercentOwner	1.10
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	18882303	shares
CY2021Q4	inpx	Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsgrantsfairvalue Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsgrantsfairvalue	4500000	USD
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	121796	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	123.66
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	5567500	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.10
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	37404	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	279.92
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	201835	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	1.26
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5450057	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	23.76
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	14285629	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.95
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	20694	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.10
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	228872	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	93.07
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	603817	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	1.35
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	18882303	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.41
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1752968	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	70.84
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	7235456	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	15.19
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-58960000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-24387000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-12582000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-4883000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-71542000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-29270000	USD
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	33000	USD
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	31000	USD
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	2376000	USD
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-1815000	USD
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	929000	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-9345000	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-5367000	USD
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	217000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	3000	USD
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-66000	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-1181000	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-5856000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-8329000	USD
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	4444000	USD
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	8273000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1412000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-56000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.0017
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.032
CY2021	inpx	Effective Income Tax Rate Reconciliation Incentive Stock Options Percent EffectiveIncomeTaxRateReconciliationIncentiveStockOptionsPercent	-0.0018
CY2020	inpx	Effective Income Tax Rate Reconciliation Incentive Stock Options Percent EffectiveIncomeTaxRateReconciliationIncentiveStockOptionsPercent	-0.004
CY2021	inpx	Effective Income Tax Rate Reconciliation Nondeductible Expense Compensation Limit Percentage EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCompensationLimitPercentage	-0.0047
CY2020	inpx	Effective Income Tax Rate Reconciliation Nondeductible Expense Compensation Limit Percentage EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCompensationLimitPercentage	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	-0.0476
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.0120
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.010
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.0032
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0
CY2021	inpx	Effective Income Tax Rate Reconciliation Provision To Return Adjustments EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustments	-0.0166
CY2020	inpx	Effective Income Tax Rate Reconciliation Provision To Return Adjustments EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustments	-0.008
CY2021	inpx	Effective Income Tax Rate Reconciliation Deferred Only Adjustment EffectiveIncomeTaxRateReconciliationDeferredOnlyAdjustment	-0.0646
CY2020	inpx	Effective Income Tax Rate Reconciliation Deferred Only Adjustment EffectiveIncomeTaxRateReconciliationDeferredOnlyAdjustment	0.045
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.0621
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.283
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0197
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.002
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	35033000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	30731000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	2540000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1253000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	131000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	138000	USD
CY2021Q4	inpx	Deferred Tax Assets Accrued Compensation DeferredTaxAssetsAccruedCompensation	96000	USD
CY2020Q4	inpx	Deferred Tax Assets Accrued Compensation DeferredTaxAssetsAccruedCompensation	86000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	345000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	151000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	0	USD
CY2020Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	7411000	USD
CY2021Q4	inpx	Deferred Tax Assets Fixed Assets DeferredTaxAssetsFixedAssets	393000	USD
CY2020Q4	inpx	Deferred Tax Assets Fixed Assets DeferredTaxAssetsFixedAssets	471000	USD
CY2021Q4	inpx	Deferred Tax Assets Unrealized Gain DeferredTaxAssetsUnrealizedGain	12876000	USD
CY2020Q4	inpx	Deferred Tax Assets Unrealized Gain DeferredTaxAssetsUnrealizedGain	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	260000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	3349000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	51674000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	43590000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	46071000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	38287000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	5603000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	5303000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	4613000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	4362000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Other Finite Lived Assets DeferredTaxLiabilitiesOtherFiniteLivedAssets	239000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Other Finite Lived Assets DeferredTaxLiabilitiesOtherFiniteLivedAssets	135000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	381000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	440000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Research And Development Costs DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts	370000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Research And Development Costs DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts	366000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	5603000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	5303000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	USD
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	4400000	USD
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	9100000	USD
CY2021Q4	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2021Q2	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2021Q3	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2021Q3	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15995000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9297000	USD
CY2021	us-gaap	Gross Profit GrossProfit	11621000	USD
CY2020	us-gaap	Gross Profit GrossProfit	6684000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-72617000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-23794000	USD
CY2021Q4	inpx	Short Term Investments Fair Value Disclosure ShortTermInvestmentsFairValueDisclosure	43125000	USD
CY2021Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	1838000	USD
CY2021Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	44963000	USD
CY2020Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	0	USD
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues	7461000	USD
CY2021	inpx	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Interest Income Expense Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetInterestIncomeExpenseNet	1627000	USD
CY2021	inpx	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain On Related Party Loan Held For Sale FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainOnRelatedPartyLoanHeldForSale	49817000	USD
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1	-57067000	USD
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	1838000	USD
CY2021	us-gaap	Revenues Revenues	15995000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-72617000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	-70130000	USD
CY2020	us-gaap	Revenues Revenues	9297000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-23794000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-29214000	USD
CY2021Q4	us-gaap	Assets Assets	156673000	USD
CY2021Q4	us-gaap	Noncurrent Assets NoncurrentAssets	38448000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	7672000	USD
CY2020Q4	us-gaap	Assets Assets	59011000	USD
CY2020Q4	us-gaap	Noncurrent Assets NoncurrentAssets	19446000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	6588000	USD
CY2021Q4	inpx	Debt Instrument Required Cash Payment Of Aggregate Cash Proceeds DebtInstrumentRequiredCashPaymentOfAggregateCashProceeds	0.06
CY2021Q4	inpx	Operating Lease Accumulated Amortization OperatingLeaseAccumulatedAmortization	1282000	USD
CY2020Q4	inpx	Operating Lease Accumulated Amortization OperatingLeaseAccumulatedAmortization	802000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1736000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2077000	USD
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	1200000	USD
CY2020	us-gaap	Operating Lease Expense OperatingLeaseExpense	5400000	USD
CY2021	inpx	Operating Lease Rent Expense OperatingLeaseRentExpense	700000	USD
CY2020	inpx	Operating Lease Rent Expense OperatingLeaseRentExpense	700000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1751000	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2104000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	643000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	647000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1108000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1457000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	733000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	471000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	378000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	258000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	103000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1943000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	192000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1751000	USD
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y4M6D
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.080
CY2019Q2	inpx	Minimum Bid Price Requirement MinimumBidPriceRequirement	1.00
CY2019Q2	inpx	Minimum Bid Price Requirement MinimumBidPriceRequirement	1.00
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-33640000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-31438000	USD
CY2021Q3	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	2962000	USD
	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	2962000	USD
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-36602000	USD
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-36602000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-34400000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-34400000	USD
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.31
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.31
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.34
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.34
CY2020Q1	inpx	Note Principal And Interest Exchanged For Common Shares NotePrincipalAndInterestExchangedForCommonShares	6465000	USD
CY2020Q1	inpx	Note Principal And Interest Exchanged For Common Shares NotePrincipalAndInterestExchangedForCommonShares	6465000	USD
CY2020Q1	inpx	Note Principal And Interest Exchanged For Common Shares NotePrincipalAndInterestExchangedForCommonShares	6465000	USD

Files In Submission

Name	View Source	Status
0001628280-22-006421-index-headers.html	Edgar Link	pending
0001628280-22-006421-index.html	Edgar Link	pending
0001628280-22-006421.txt	Edgar Link	pending
0001628280-22-006421-xbrl.zip	Edgar Link	pending
exhibit1037-kareemmirfanco.htm	Edgar Link	pending
exhibit1040-amendment3toil.htm	Edgar Link	pending
exhibit211-listofsubsidiar.htm	Edgar Link	pending
exhibit231-marcum20211231.htm	Edgar Link	pending
exhibit311-inpxx20211231.htm	Edgar Link	pending
exhibit312-inpxx20211231.htm	Edgar Link	pending
exhibit321-certification.htm	Edgar Link	pending
exhibit416-descriptionofre.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
inpx-20211231.htm	Edgar Link	pending
inpx-20211231.xsd	Edgar Link	pending
inpx-20211231_cal.xml	Edgar Link	unprocessable
inpx-20211231_def.xml	Edgar Link	unprocessable
inpx-20211231_htm.xml	Edgar Link	completed
inpx-20211231_lab.xml	Edgar Link	unprocessable
inpx-20211231_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R117.htm	Edgar Link	pending
R118.htm	Edgar Link	pending
R119.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R120.htm	Edgar Link	pending
R121.htm	Edgar Link	pending
R122.htm	Edgar Link	pending
R123.htm	Edgar Link	pending
R124.htm	Edgar Link	pending
R125.htm	Edgar Link	pending
R126.htm	Edgar Link	pending
R127.htm	Edgar Link	pending
R128.htm	Edgar Link	pending
R129.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R130.htm	Edgar Link	pending
R131.htm	Edgar Link	pending
R132.htm	Edgar Link	pending
R133.htm	Edgar Link	pending
R134.htm	Edgar Link	pending
R135.htm	Edgar Link	pending
R136.htm	Edgar Link	pending
R137.htm	Edgar Link	pending
R138.htm	Edgar Link	pending
R139.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R140.htm	Edgar Link	pending
R141.htm	Edgar Link	pending
R142.htm	Edgar Link	pending
R143.htm	Edgar Link	pending
R144.htm	Edgar Link	pending
R145.htm	Edgar Link	pending
R146.htm	Edgar Link	pending
R147.htm	Edgar Link	pending
R148.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$XTIA
XTI Aerospace, Inc. Stock $xtia

2021 Q4 Form 10-K Financial Statement

#000162828022006421 Filed on March 16, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XTIA XTI Aerospace, Inc. Stock $xtia

2021 Q4 Form 10-K Financial Statement

#000162828022006421 Filed on March 16, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XTIA
XTI Aerospace, Inc. Stock $xtia